Abstract

BackgroundRecent evidence suggests that the faecal immunochemical test (FIT) can rule out colorectal cancer (CRC) in symptomatic patients. To date, there is no research on usability and perception of FIT for these patients.AimTo measure variation in attitudes and perception of FIT in patients with suspected CRC symptoms.Design & settingA cross-sectional survey of a subset of participants of the NICE FIT study.MethodA questionnaire was co-developed with patients covering four themes on a Likert scale: FIT feasibility, faecal aversion, patient knowledge, and future intentions. Questionnaire and FIT kits were sent to patients with suspected CRC symptoms participating in the NICE FIT study. Logistic regression explored differences in patients’ test perception by ethnic group, language, age, location, deprivation, FIT use, and previous experience.ResultsA total of 1151 questionnaires were analysed; 90.2% (95% confidence interval [CI] = 88.3% to 91.8%) of patients found faecal collection straightforward, 76.3% (95% CI = 73.7% to 78.6%) disagreed FIT was unhygienic, and 78.1% (95% CI = 75.6% to 80.4%) preferred FIT to colonoscopy. Preference for FIT over colonoscopy was weaker in patients aged 40–64 years than those >65 years (odds ratio [OR] 0.60; 95% CI = 0.43 to 0.84). Intention to use FIT again was stronger in patients who successfully used FIT than those unsuccessful (OR 11.08; 95% CI = 2.74 to 44.75), and white compared with non-white patients assessed (OR 3.20; 95% CI = 1.32 to 7.75).ConclusionWhile most patients found FIT practical and hygienic, perception differences were found. Strategies to engage patients with more negative FIT perception should underpin symptomatic FIT pathways.

Highlights

  • The faecal immunochemical test (FIT) is a non-invasive, quantitative immunoassay which detects the globin moiety of haemoglobin in faeces (f-Hb)

  • We studied patients referred under the 2WW pathway with suspected colorectal cancer (CRC) symptoms recruited into the NICE Faecal Immunochemical Test (FIT) study, a multicentre, double-blinded diagnostic accuracy study in 50 English National Health Service hospitals which determined the sensitivity and specificity of FIT for CRC when compared to colonoscopy

  • Packs with questionnaires were sent to 3760 patients taking part in the NICE FIT study; 1151 (31%) questionnaires were returned and analysed

Read more

Summary

Introduction

The faecal immunochemical test (FIT) is a non-invasive, quantitative immunoassay which detects the globin moiety of haemoglobin in faeces (f-Hb). [12], [13] This indicates the need for better understanding of the variation of patient perception and attitudes to FIT when used in urgent referral pathways, to inform design of future pathways in primary and secondary care and improve patient experience. We studied patients referred under the 2WW pathway with suspected CRC symptoms recruited into the NICE FIT study, a multicentre, double-blinded diagnostic accuracy study in 50 English National Health Service hospitals which determined the sensitivity and specificity of FIT for CRC when compared to colonoscopy [12] The aim was to determine variation in attitudes, perception and usability of FIT in these symptomatic patients.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call